Q. I’ve been hearing a lot of conflicting information about GLP-1 products. What are they and how can they be helpful for me and my diabetes?
Diabetes treatment is improving; one big change is using GLP-1 receptor agonists. These medicines help control blood sugar and weight management, essential for people with type 2 diabetes. GLP-1 therapy works best when combined with changes in behavior and lifestyle, especially with nutrition and weight management.
Let’s examine how GLP-1 receptor agonists, nutrition and weight loss work together to improve the health of people with diabetes. Combining these medicines with lifestyle changes can help people manage their diabetes better and improve their overall quality of life.
GLP-1 is a hormone produced in the small intestine that has several functions. It helps release insulin from the pancreas and stops the hormone glucagon, which raises blood sugar levels. By doing this, GLP-1 helps prevent too much glucose from getting into the blood. It also slows down how quickly the stomach empties and makes you feel full by affecting the brain’s hunger signals. GLP-1 agonist medicines act like this hormone.
GLP-1 can help with weight loss by reducing appetite, making you feel full longer and decreasing cravings. However, it can also cause side effects like nausea, reflux, constipation and possible muscle loss or dehydration.
To get the most out of GLP-1 receptor agonists, follow good nutrition strategies such as practicing mindful eating, consuming adequate protein, focusing on fiber intake, consuming smaller, balanced meals more frequently, ensuring adequate hydration and finding an exercise routine you enjoy. An important strategy for implementing balanced nutrition is working closely with a registered dietitian.
Your registered dietitian can offer personalized guidance to effectively assist you in managing your diet while taking a GLP-1 medication to optimize treatment outcomes, address potential side effects and support long-term weight loss and diabetes management. More research and product innovation is coming, and this will be an area to keep an eye on for new recommendations and progress in the next few years.